ArticlePloS one2016

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.

Henrik H Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.